258 related articles for article (PubMed ID: 18375116)
1. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.
Chiappetta G; Ferraro A; Vuttariello E; Monaco M; Galdiero F; De Simone V; Califano D; Pallante P; Botti G; Pezzullo L; Pierantoni GM; Santoro M; Fusco A
Eur J Cancer; 2008 May; 44(7):1015-21. PubMed ID: 18375116
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
[TBL] [Abstract][Full Text] [Related]
3. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.
Jin L; Lloyd RV; Nassar A; Lappinga PJ; Sebo TJ; Swartz K; Seys AR; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Zhang J
Diagn Mol Pathol; 2011 Jun; 20(2):71-80. PubMed ID: 21532495
[TBL] [Abstract][Full Text] [Related]
4. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
5. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours.
Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P
J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122
[TBL] [Abstract][Full Text] [Related]
6. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
[TBL] [Abstract][Full Text] [Related]
7. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
[TBL] [Abstract][Full Text] [Related]
8. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
10. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
[TBL] [Abstract][Full Text] [Related]
11. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers?
Letsas KP; Vartholomatos G; Tsepi C; Tsatsoulis A; Frangou-Lazaridis M
Neoplasma; 2007; 54(1):57-62. PubMed ID: 17203893
[TBL] [Abstract][Full Text] [Related]
12. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of mucins 1-6 in papillary thyroid carcinoma: evidence for transformation-dependent post-translational modifications of MUC1 in situ.
Magro G; Schiappacassi M; Perissinotto D; Corsaro A; Borghese C; Belfiore A; Colombatti A; Grasso S; Botti C; Bombardieri E; Perris R
J Pathol; 2003 Jul; 200(3):357-69. PubMed ID: 12845632
[TBL] [Abstract][Full Text] [Related]
14. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules.
Lappinga PJ; Kip NS; Jin L; Lloyd RV; Henry MR; Zhang J; Nassar A
Cancer Cytopathol; 2010 Oct; 118(5):287-97. PubMed ID: 20597139
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
17. High periostin expression correlates with aggressiveness in papillary thyroid carcinomas.
Puppin C; Fabbro D; Dima M; Di Loreto C; Puxeddu E; Filetti S; Russo D; Damante G
J Endocrinol; 2008 May; 197(2):401-8. PubMed ID: 18434370
[TBL] [Abstract][Full Text] [Related]
18. HMGA2 expression in a canine model of prostate cancer.
Winkler S; Murua Escobar H; Meyer B; Simon D; Eberle N; Baumgartner W; Loeschke S; Nolte I; Bullerdiek J
Cancer Genet Cytogenet; 2007 Sep; 177(2):98-102. PubMed ID: 17854662
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
[TBL] [Abstract][Full Text] [Related]
20. The cellular localization of autotaxin impacts on its biological functions in human thyroid carcinoma cells.
Seifert A; Klonisch T; Wulfaenger J; Haag F; Dralle H; Langner J; Hoang-Vu C; Kehlen A
Oncol Rep; 2008 Jun; 19(6):1485-91. PubMed ID: 18497954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
